Top Markets
Coin of the day
Enochian Biosciences, Inc. Enochian Biosciences, Inc.

Enochian Biosciences, Inc.

ENOB
Pozycja w akcjach #19952
Enochian Biosciences, Inc. is a pre-clinical biotechnology firm dedicated to... Enochian Biosciences, Inc. is a pre-clinical biotechnology firm dedicated to the research and advancement of novel pharmaceutical and biological agents. Its primary focus lies in developing treatments for a range of human diseases, including human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza, coronavirus infections, and various cancers. The company's leading investigational products encompass ENOB-HV-01, an autologous therapy aimed at achieving an HIV cure; ENOB-HV-11, a preventative HIV vaccine candidate; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, which targets the HBV polymerase. Beyond these primary programs, Enochian Biosciences' developmental pipeline also features ENOB-DC-11, an off-the-shelf dendritic cell vaccine designed for multiple solid tumors, and ENOB-DC-21, a non-specific vaccine intended for direct intratumoral injection. The company collaborates strategically with prominent research organizations such as The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. Founded in 2017, Enochian Biosciences, Inc. operates from its headquarters in Los Angeles, California.
Cena akcji
$2.60
Ostatnia synchronizacja: 2023-08-29
Kapitalizacja rynkowa
$145.54M
Zmiana (1 dzień)
9.24%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Enochian Biosciences, Inc. (ENOB)

Kategoria

Historia ceny akcji dla Enochian Biosciences, Inc. (ENOB)
Najwyższa cena zamknięcia: $1.56 dnia 2023-08-01

Najniższa cena zamknięcia: $6.00 dnia 2018-02-01
Historia cen akcji firmy Enochian Biosciences, Inc. od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 22.24%
2022 -85.76%
2021 198.71%
2020 -47.16%
2019 -18.78%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.65 -12.25%
AU
$772.27 7.33%
CH